论文信息 - Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma - 字舞流文

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

P. Wen | R. Jain | J. D. de Groot | H. Colman | J. Yearley | T. Kaley | D. Reardon | L. Nghiemphu | A. Muzikansky | A. Molinaro | Jennifer L. Clarke | D. Duda | Christine S McCluskey | W. Blumenschein | D. Cote | K. Peters | Sarah C. Gaffey | J. Jordan | L. Nayak | Qing Zhao | Mariano Severgnini | J. Clarke | T. Smith | D. Duda | Christine McCluskey